AR041428A1 - Forma de dosificacion de ibuprofeno sodico - Google Patents

Forma de dosificacion de ibuprofeno sodico

Info

Publication number
AR041428A1
AR041428A1 ARP030103544A ARP030103544A AR041428A1 AR 041428 A1 AR041428 A1 AR 041428A1 AR P030103544 A ARP030103544 A AR P030103544A AR P030103544 A ARP030103544 A AR P030103544A AR 041428 A1 AR041428 A1 AR 041428A1
Authority
AR
Argentina
Prior art keywords
weight
ibuprofen
sodium ibuprofen
tablet core
hydrated sodium
Prior art date
Application number
ARP030103544A
Other languages
English (en)
Original Assignee
Roche Consumer Health Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28796671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR041428(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Consumer Health Ag filed Critical Roche Consumer Health Ag
Publication of AR041428A1 publication Critical patent/AR041428A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una tableta no efervescente de ibuprofeno sódico que comprende un núcleo de tableta y, si se desea, una cubierta de azúcar o de película, en la cual el núcleo de tableta, con referencia al peso del núcleo de tableta, consiste en de 50 a 100% en peso de ibuprofeno sódico hidratado y de 50 a 0% en peso de componente de material auxiliar, no conteniendo ni lubricante ni disgregante, y en la cual el ibuprofeno sódico hidratado tiene un contenido de agua de desde 8 a 16% en peso, preferentemente de desde 11 a 16% en peso, posee una dureza suficiente, es comparativamente pequena y produce un incremento particularmente rápido en el nivel en sangre y con ello un comienzo acelerado del efecto analgésico. En oposición a la doctrina corriente el ibuprofeno sódico hidratado que tiene un contenido de agua adecuado es suficientemente comprensible.
ARP030103544A 2002-10-14 2003-09-29 Forma de dosificacion de ibuprofeno sodico AR041428A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01703/02A CH693586A8 (de) 2002-10-14 2002-10-14 Darreichungsform von Ibuprofen-Natrium.

Publications (1)

Publication Number Publication Date
AR041428A1 true AR041428A1 (es) 2005-05-18

Family

ID=28796671

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103544A AR041428A1 (es) 2002-10-14 2003-09-29 Forma de dosificacion de ibuprofeno sodico

Country Status (32)

Country Link
US (1) US20040102522A1 (es)
EP (1) EP1410793B1 (es)
JP (1) JP4608316B2 (es)
KR (1) KR101046894B1 (es)
CN (1) CN100592909C (es)
AR (1) AR041428A1 (es)
AT (1) ATE309789T1 (es)
AU (1) AU2003266094B2 (es)
BR (1) BRPI0315248B1 (es)
CA (1) CA2500987A1 (es)
CH (1) CH693586A8 (es)
CO (1) CO5700709A2 (es)
DE (1) DE50301661D1 (es)
DK (1) DK1410793T3 (es)
EA (1) EA007914B1 (es)
EC (1) ECSP055793A (es)
ES (1) ES2249702T3 (es)
HR (1) HRP20050429A2 (es)
IL (1) IL167357A (es)
MA (1) MA27490A1 (es)
MX (1) MXPA05003592A (es)
MY (1) MY132858A (es)
NO (1) NO20052343L (es)
NZ (1) NZ539405A (es)
PA (1) PA8586101A1 (es)
PE (1) PE20040417A1 (es)
PL (1) PL376177A1 (es)
SI (1) SI1410793T1 (es)
TW (1) TWI262800B (es)
UA (1) UA86751C2 (es)
WO (1) WO2004035024A1 (es)
ZA (1) ZA200502925B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3920358A1 (de) * 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20050176809A1 (en) * 2004-02-05 2005-08-11 Rodlen Laboratories, Inc. Method and compositions for treatment of painful disorders
CA2576642A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising a nsaid and a sugar alcohol made by melt extrusion
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CA2610343A1 (en) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited Release-control composition
JP2008534477A (ja) 2005-03-22 2008-08-28 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 可溶化イブプロフェン
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
DE102006029233A1 (de) * 2006-06-26 2007-12-27 Liedtke, Rainer K., Dr. Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika
CL2007002425A1 (es) * 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
EP2309988B1 (en) * 2008-07-21 2015-11-25 SI Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
HUE037827T2 (hu) * 2009-06-22 2018-09-28 Wyeth Llc Nátrium-ibuprofen tabletták és eljárások nátrium-ibuprofent tartalmazó gyógyszerészeti készítmények elõállítására
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
US20180078516A1 (en) * 2016-09-19 2018-03-22 Innovazone Labs LLC Pharmaceutical Composition of Ibuprofen Sodium for Oral Administration
CN113893227B (zh) * 2021-11-18 2023-04-14 山东则正医药技术有限公司 布洛芬片的制备原料、制备方法和布洛芬片

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104648A (en) * 1989-02-02 1992-04-14 Mallinckrodt Specialty Chemicals Company High ibuprofen content granulations
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US6083430A (en) * 1994-10-28 2000-07-04 Fuisz Technologies Ltd. Method of preparing a dosage unit by direct tableting and product therefrom
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica

Also Published As

Publication number Publication date
CH693586A5 (de) 2003-10-31
ECSP055793A (es) 2005-08-11
WO2004035024A1 (en) 2004-04-29
HRP20050429A2 (en) 2005-06-30
SI1410793T1 (sl) 2006-04-30
CN100592909C (zh) 2010-03-03
MXPA05003592A (es) 2005-09-30
DK1410793T3 (da) 2006-04-03
DE50301661D1 (de) 2005-12-22
US20040102522A1 (en) 2004-05-27
EA007914B1 (ru) 2007-02-27
ES2249702T3 (es) 2006-04-01
TWI262800B (en) 2006-10-01
CN1705470A (zh) 2005-12-07
EP1410793A1 (de) 2004-04-21
NO20052343L (no) 2005-06-02
ATE309789T1 (de) 2005-12-15
CH693586A8 (de) 2003-12-15
BRPI0315248B1 (pt) 2016-08-02
PL376177A1 (en) 2005-12-27
AU2003266094B2 (en) 2009-04-23
CA2500987A1 (en) 2004-04-29
PE20040417A1 (es) 2004-07-14
MY132858A (en) 2007-10-31
JP2006505558A (ja) 2006-02-16
KR20050083760A (ko) 2005-08-26
AU2003266094A1 (en) 2004-05-04
ZA200502925B (en) 2006-02-22
PA8586101A1 (es) 2005-05-10
TW200407175A (en) 2004-05-16
BR0315248A (pt) 2005-08-23
EP1410793B1 (de) 2005-11-16
CO5700709A2 (es) 2006-11-30
JP4608316B2 (ja) 2011-01-12
IL167357A (en) 2009-05-04
EA200500649A1 (ru) 2005-10-27
UA86751C2 (ru) 2009-05-25
NZ539405A (en) 2006-12-22
KR101046894B1 (ko) 2011-07-06
MA27490A1 (fr) 2005-08-01

Similar Documents

Publication Publication Date Title
AR041428A1 (es) Forma de dosificacion de ibuprofeno sodico
BR122018068298B8 (pt) processo para a produção de um comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
AR100291A2 (es) Composición catártica
AR051102A1 (es) Composiciones para el tratamiento de la ropa.
AR054139A1 (es) Formulacion modificada y de liberacion inmediata de esferas de memantina
ECSP056099A (es) Comprimidos en mezcla con hipoclorito de calcio
AR036813A1 (es) Composiciones farmaceuticas
PA8638201A1 (es) Forma cristalina alfa del ranelato de estroncio procedimiento para su preparacion y composiciones farmaceuticas que la contienen
IS8058A (is) Sýklísk súlfónamíð til að hamla gamma seytiasa
BRPI0510619A (pt) preparação e cápsula contendo a mesma
ATE292460T1 (de) Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels
AR018270A1 (es) Pastilla para inodoros y método para prepararla.
ES2182255T3 (es) Agente de blanqueo fluorescente.
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
ATE509854T1 (de) Verbesserungen in behältern oder diese betreffend
AR048775A1 (es) Un medicamento que comprende ptx3 y un agente antifungico para el tratamiento de infecciones fungicas particularmente aspergilosis
AR024959A1 (es) Una composicion farmaceutica liquida basada en paracetamol
BRPI0513257A (pt) composição farmacêutica lìquida
ES2550351T3 (es) Liposoma termolábil con una temperatura de liberación regulada
AR044675A1 (es) Metodo para el tratamiento de la esquizofrenia en un paciente con sobrepeso
BRPI0415624A (pt) forma não-efervescente de sódio naproxeno compreendendo, entre outros, hidrogeno carbonato de sódio
AR057413A1 (es) Polvo desintegrable oralmente que comprende cilostazol
BR0312963A (pt) Couro antimicrobiano durável
UY27741A1 (es) Supositorios de meloxicam
UY28023A1 (es) Forma de dosificacion de ibuprofeno sodico

Legal Events

Date Code Title Description
FB Suspension of granting procedure